DEUTSCHE BANK AG\ - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$130,967
-43.6%
55,028
+13.6%
0.00%
Q2 2023$232,080
-33.1%
48,451
-20.8%
0.00%
Q1 2023$347,078
+30.5%
61,213
+28.9%
0.00%
Q4 2022$265,911
+31.6%
47,484
+50.9%
0.00%
Q3 2022$202,000
+47.4%
31,477
-21.3%
0.00%
Q2 2022$137,000
-65.7%
40,014
-28.7%
0.00%
Q1 2022$399,000
-82.9%
56,159
-79.9%
0.00%
-100.0%
Q4 2021$2,333,000
+326.5%
279,979
+256.5%
0.00%
Q3 2021$547,000
-51.2%
78,542
+67.2%
0.00%
-100.0%
Q2 2021$1,121,000
-13.5%
46,966
-25.3%
0.00%0.0%
Q1 2021$1,296,000
+16.0%
62,914
+38.0%
0.00%0.0%
Q4 2020$1,117,000
+36.2%
45,592
+57.5%
0.00%0.0%
Q3 2020$820,000
+638.7%
28,953
+23.9%
0.00%
Q2 2020$111,000
+146.7%
23,368
+88.4%
0.00%
Q1 2020$45,000
+2.3%
12,401
-5.6%
0.00%
Q4 2019$44,000
+10.0%
13,143
+28.6%
0.00%
Q3 2019$40,000
-13.0%
10,222
-31.8%
0.00%
Q2 2019$46,000
-71.1%
14,996
-35.9%
0.00%
Q1 2019$159,000
+55.9%
23,387
+2.7%
0.00%
Q4 2018$102,000
-85.5%
22,766
-75.5%
0.00%
Q3 2018$705,000
-8.6%
93,095
+3.8%
0.00%
Q2 2018$771,000
-40.1%
89,714
-48.9%
0.00%
-100.0%
Q1 2018$1,287,000
-44.1%
175,667
-22.7%
0.00%0.0%
Q4 2017$2,302,000
+55.6%
227,190
+146.1%
0.00%0.0%
Q3 2017$1,479,000
-28.0%
92,316
-49.3%
0.00%0.0%
Q2 2017$2,054,000
-28.3%
181,962
-28.4%
0.00%
-50.0%
Q1 2017$2,864,000
-17.2%
254,290
-27.3%
0.00%
-33.3%
Q4 2016$3,460,000
-18.5%
349,643
+1.2%
0.00%0.0%
Q3 2016$4,246,000
+1116.6%
345,569
+2761.4%
0.00%
Q2 2016$349,000
+52.4%
12,077
+39.4%
0.00%
Q1 2016$229,000
+205.3%
8,666
+305.3%
0.00%
Q4 2015$75,000
+7.1%
2,138
-10.8%
0.00%
Q3 2015$70,000
-91.3%
2,398
-87.7%
0.00%
-100.0%
Q2 2015$808,00019,4740.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders